Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Farmers Insurance
Cipla
Dow
Fish and Richardson
Chubb
Johnson and Johnson
Healthtrust
Mallinckrodt
UBS

Generated: January 16, 2018

DrugPatentWatch Database Preview

METHOCARBAMOL Drug Profile

« Back to Dashboard

Which patents cover Methocarbamol, and what generic alternatives are available?

Methocarbamol is a drug marketed by Marsam Pharms Llc, Watson Labs, Aurobindo Pharma Ltd, Luitpold Pharms Inc, Monterey Pharms Llc, Mylan Institutional, Renaissance Ssa Llc, Sagent Pharms, Somerset Theraps Llc, Able, Am Therap, Ascot, Atlas Pharms Llc, Austarpharma Llc, Beximco Pharms Usa, Clonmel Hlthcare, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Lannett Holdings Inc, Mylan, Nylos, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Vintage Pharms, Mcneil, Par Pharm, and Stevens J. and is included in sixty-seven NDAs.

The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Drug patent expirations by year for METHOCARBAMOL
Pharmacology for METHOCARBAMOL

US Patents and Regulatory Information for METHOCARBAMOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METHOCARBAMOL methocarbamol TABLET;ORAL 085192-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nylos METHOCARBAMOL methocarbamol TABLET;ORAL 085033-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Inwood Labs METHOCARBAMOL methocarbamol TABLET;ORAL 085137-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm METHOCARBAMOL methocarbamol TABLET;ORAL 085718-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm METHOCARBAMOL methocarbamol TABLET;ORAL 087589-001 Jan 22, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Prinston Inc METHOCARBAMOL methocarbamol TABLET;ORAL 086988-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane METHOCARBAMOL methocarbamol TABLET;ORAL 088646-001 Feb 29, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHOCARBAMOL methocarbamol TABLET;ORAL 087282-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm METHOCARBAMOL methocarbamol TABLET;ORAL 087590-001 Jan 22, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Intl Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 085159-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Express Scripts
Dow
UBS
Julphar
Boehringer Ingelheim
McKesson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot